Loading viewer...
investor_presentation
Format: PDF investor_presentation
Leading independent biologics CDMO offering comprehensive services from cell line development through commercial manufacturing. Company highlights experienced management, recent facility expansions in mammalian and cell/gene therapy capabilities, and a strong regulatory track record serving a growing biopharmaceutical pipeline.
investor_presentation
27 Pages
Meta Materials
IOL Chemicals Pharmaceuticals Q1FY23 2022 Investor Presentation
investor_presentationinvestor_presentation
27 Pages
IOL Chemicals and Pharmaceuticals Limited
ATS BioDot Acquisition 2021
investor_presentationinvestor_presentation
11 Pages
Applied Test Systems Inc.